Literature DB >> 25193695

Knockdown of kinesin KIF11 abrogates directed migration in response to epidermal growth factor-mediated chemotaxis.

Fang Wang1, Stanley Li Lin2.   

Abstract

Establishment of microtubule polarity is critical for directional cell migration involved in morphogenesis, differentiation, cell division, and metastasis. Current models, involving iterative microtubule capture and inactivation of microtubule depolymerizing mechanisms at the leading edge, cannot account for the biased migration exhibited by cells in culture in the absence of directional cues, suggesting central mechanisms governing microtubule polarity remain unknown. We engineered two human MDA-MB-231/IMP1 breast carcinoma cell lines, denoted kdKIF11-1 and kdKIF11-2, in which the kinesin KIF11 (also known as Eg5) was stably knocked down by two different shRNAs. Western blot analysis showed knockdown by each shRNA decreased KIF11 expression by 58% and 79% for kdKIF11-1 and kdKIF11-2, respectively, whereas Rac1 expression was unaffected. All cell lines retained a well-defined microtubule structure. Compared to cells infected with the control viral vector, both KIF11 knockdown cell lines displayed a 14-45% increase in cell motility in a scratch wound healing assay. In contrast, KIF11 knockdown decreased invasion by 70%, compared to the control, as measured by invasion through Matrigel-coated transwells. To determine whether the reduction in invasion was due to reduced chemotaxis, we substituted collagen for Matrigel in the transwell assay and similarly observed a 44-54% reduction in migration, using EGF as the chemoattractant. However, when including EGF in both the upper and lower chambers of the transwell to stimulate migration but eliminate chemotaxis, transwell migration decreased for the control cell line only, indicating that KIF11 knockdown did not impair migration, but severely impaired chemotaxis. We conclude KIF11 is a key downstream molecule that responds to directional cues in chemotaxis to govern the direction of migration.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chemotaxis; Epidermal growth factor; Invasion; KIF11; Migration

Mesh:

Substances:

Year:  2014        PMID: 25193695     DOI: 10.1016/j.bbrc.2014.08.136

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  The mitotic kinesin KIF11 is a driver of invasion, proliferation, and self-renewal in glioblastoma.

Authors:  Monica Venere; Craig Horbinski; James F Crish; Xun Jin; Amit Vasanji; Jennifer Major; Amy C Burrows; Cathleen Chang; John Prokop; Quilian Wu; Peter A Sims; Peter Canoll; Matthew K Summers; Steven S Rosenfeld; Jeremy N Rich
Journal:  Sci Transl Med       Date:  2015-09-09       Impact factor: 17.956

2.  A novel and selective inhibitor of PKC ζ potently inhibits human breast cancer metastasis in vitro and in mice.

Authors:  Jing Wu; Shuye Liu; Zhijuan Fan; Lei Zhang; Yaqiong Tian; Rui Yang
Journal:  Tumour Biol       Date:  2016-01-05

3.  The kinesin Eg5 inhibitor K858 induces apoptosis and reverses the malignant invasive phenotype in human glioblastoma cells.

Authors:  Ludovica Taglieri; Giovanna Rubinacci; Anna Giuffrida; Simone Carradori; Susanna Scarpa
Journal:  Invest New Drugs       Date:  2017-09-30       Impact factor: 3.850

Review 4.  Impacts of activation of the mitogen-activated protein kinase pathway in pancreatic cancer.

Authors:  Toru Furukawa
Journal:  Front Oncol       Date:  2015-02-04       Impact factor: 6.244

5.  Overexpression of EZH2/NSD2 Histone Methyltransferase Axis Predicts Poor Prognosis and Accelerates Tumor Progression in Triple-Negative Breast Cancer.

Authors:  Bo Gao; Xiumin Liu; Zhengjin Li; Lixian Zhao; Yun Pan
Journal:  Front Oncol       Date:  2021-02-16       Impact factor: 6.244

Review 6.  Kinesin spindle protein inhibitors in cancer: from high throughput screening to novel therapeutic strategies.

Authors:  Rand Shahin; Salah Aljamal
Journal:  Future Sci OA       Date:  2022-02-21

7.  KIF11 is required for proliferation and self-renewal of docetaxel resistant triple negative breast cancer cells.

Authors:  Meng Jiang; Huiru Zhuang; Rui Xia; Lei Gan; Yuantao Wu; Junzhe Ma; Yihui Sun; Zhixiang Zhuang
Journal:  Oncotarget       Date:  2017-09-08

8.  lncRNA Expression Reveals the Potential Regulatory Roles in Hepatocyte Proliferation during Rat Liver Regeneration.

Authors:  Haijing Bai; Wei Jin; Jianlin Guo; Yi Ding; Cuifang Chang; Xueqiang Guo; Yaping Song; Jingbo Zhang; Cunshuan Xu
Journal:  Biomed Res Int       Date:  2019-11-11       Impact factor: 3.411

9.  KIF11 promotes cell proliferation via ERBB2/PI3K/AKT signaling pathway in gallbladder cancer.

Authors:  Dang Wei; Bian Rui; Fan Qingquan; Cai Chen; Hu Yun Ping; Song Xiaoling; Weng Hao; Gu Jun
Journal:  Int J Biol Sci       Date:  2021-01-01       Impact factor: 6.580

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.